Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical StudyACCESSWIRE•31/08/2026•08:30 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
